Effect of vaccines on bacterial meningitis worldwide
Summary Three bacteria—Haemophilus influenzae, Streptococcus pneumoniae, and
Neisseria meningitidis—account for most acute bacterial meningitis. Measurement of the …
Neisseria meningitidis—account for most acute bacterial meningitis. Measurement of the …
[HTML][HTML] Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization …
Abstract In 2003 the World Health Organization (WHO) convened a working group and
published a set of standard methods for studies measuring nasopharyngeal carriage of …
published a set of standard methods for studies measuring nasopharyngeal carriage of …
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study
SN Ladhani, S Collins, A Djennad… - The Lancet Infectious …, 2018 - thelancet.com
Summary Background Pneumococcal conjugate vaccines (PCVs) have substantially
reduced the incidence of invasive pneumococcal disease caused by vaccine serotypes; …
reduced the incidence of invasive pneumococcal disease caused by vaccine serotypes; …
[HTML][HTML] Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an …
Background The 13-valent pneumococcal conjugate vaccine (PCV13) protects against key
serotypes that increased after routine immunisation with the seven-valent vaccine (PCV7) …
serotypes that increased after routine immunisation with the seven-valent vaccine (PCV7) …
Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites
DR Feikin, EW Kagucia, JD Loo, R Link-Gelles… - PLoS …, 2013 - journals.plos.org
Background Vaccine-serotype (VT) invasive pneumococcal disease (IPD) rates declined
substantially following introduction of 7-valent pneumococcal conjugate vaccine (PCV7) into …
substantially following introduction of 7-valent pneumococcal conjugate vaccine (PCV7) into …
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
Background The seven-valent pneumococcal conjugate vaccine (PCV7) has reduced
vaccine-type (VT) invasive pneumococcal disease but increases in non-vaccine-type (NVT) …
vaccine-type (VT) invasive pneumococcal disease but increases in non-vaccine-type (NVT) …
Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis
Background The full extent to which childhood pneumococcal conjugate vaccines (PCV) can
indirectly reduce illness in unvaccinated populations is not known. We aimed to estimate the …
indirectly reduce illness in unvaccinated populations is not known. We aimed to estimate the …
Streptococcus pneumoniae: Invasion and Inflammation
AJ Loughran, CJ Orihuela, EI Tuomanen - Microbiology spectrum, 2019 - Am Soc Microbiol
Streptococcus pneumoniae (the pneumoccus) is the leading cause of otitis media,
community-acquired pneumonia, and bacterial meningitis. The success of the …
community-acquired pneumonia, and bacterial meningitis. The success of the …
Making sense of differences in pneumococcal serotype replacement
JA Lewnard, WP Hanage - The Lancet Infectious Diseases, 2019 - thelancet.com
Serotype replacement in invasive pneumococcal disease threatens to undermine the most
costly vaccination programme currently undertaken. However, the effects of replacement on …
costly vaccination programme currently undertaken. However, the effects of replacement on …
The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England
OBJECTIVE: To inform national policy making on the use of the 13-valent pneumococcal
vaccine among risk groups we estimated the increased risk of invasive pneumococcal …
vaccine among risk groups we estimated the increased risk of invasive pneumococcal …